Hundreds of lawsuits have been filed on behalf of Risperdal users who developed gynecomastia. These lawsuits allege that Janssen Pharmaceuticals, the maker of Risperdal, knew that its drug could cause abnormal breast growth in young men, yet failed to adequately warn doctors and patients about this risk. Despite knowing that safer and less expensive antipsychotic drugs were available, Janssen continued to market Risperdal as a safe and effective treatment, putting profits ahead of patient safety, the lawsuits claim.
Have you or a loved one developed gynecomastia? Do you have question about your legal rights? To learn more about filing a lawsuit, complete our free case review form today. There is no cost or obligation.
Plaintiffs allege that Risperdal is defective in design, manufacture, and marketing. This means that Janssen allegedly failed to properly design, manufacture and test Risperdal before releasing it to the public, and as a result, provided patients with misleading information about the drug.
The lawsuits also allege the following:
One plaintiff claims that he began using Risperdal when he was just nine years old. After using the drug for several years, he was diagnosed with gynecomastia, and he claims a mastectomy is necessary to remove the excess breast tissue. In addition to abnormal breast growth, he alleges he also suffered from rapid weight gain and damage to his endocrine system and sexual organs.
Those taking legal action against Janssen are seeking compensation for bodily and mental injury, past and future medical expenses, disfigurement, embarrassment and pain and suffering.
Physicians believe that schizophrenia is the result of excessive dopamine in the body, which Risperdal works to regulate; however, suppressing dopamine may cause a release of the hormone prolactin, which is only found naturally in breastfeeding women and causes breast tissue to enlarge.
Numerous studies have linked Risperdal to increased levels of prolactin. One study, published in the Journal of Clinical Psychopharmacology, found that prolactin levels in adolescent males increased significantly when they used Risperdal. Furthermore, another study found that even after patients stopped taking Risperdal, elevated prolactin levels remained in their systems for as long as two years, according to a 2009 publication in the Journal of Child and Adolescent Psychopharmacology.
This is not a class action lawsuit, but a mass tort. (For more information on the difference between these two forms of litigation, visit our page "Why Isn't This a Class Action?") Risperdal victims or loved ones acting on their behalf will need to file individual lawsuits to recover compensation for their specific losses. If you need to find an attorney or want more information on filing a lawsuit, contact ClassAction.org by using the form on the right. We have established relationships with attorneys across the country and may be able to connect you with someone who can help.
Defective drug attorneys usually work on a contingency-fee basis. This means that you will only have to pay your attorney if your case is successful. In these cases, your attorney will typically collect one-third of your final verdict or settlement.
Were you or a loved one diagnosed with gynecomastia? If so, ClassAction.org would like you to know that there may still be time to join this growing litigation. For more information on whether you may be able to file a lawsuit seeking compensation for your injuries, fill out our free case review form today.
Here at ClassAction.org, we are constantly combing through newly-filed lawsuits and court documents to uncover information that is valuable to our readers. What we found when reading through… More
On Tuesday, plaintiffs asked a Pennsylvania judge to lift a protective order on documents from pre-trial proceedings that allegedly support a connection between the antipsychotic drug Risperdal and… More
Did Johnson & Johnson know about - and try to hide – the side effects of Risperdal, the company's popular anti-psychotic? The possibility has been raised by newly released internal… More
Johnson & Johnson has agreed to pay more than $2.2 billion to resolve criminal and civil liability arising from allegations that the company encouraged doctors to prescribe Risperdal, Invega, and… More